From: Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
Clinical features | Lung cancer | Benign diseases | Total |
---|---|---|---|
Age | Â | Â | Â |
> 60 | 12 (42.86%) | 4 (13.79%) | 16 (28.07%) |
≤ 60 | 16 (57.14%) | 25 (86.21%) | 41 (71.93%) |
Sex | Â | Â | Â |
Male | 14 (50%) | 12 (41.38%) | 26 (45.61%) |
Female | 14 (50%) | 17 (58.62%) | 31 (54.39%) |
Smoking history | Â | Â | Â |
Current | 7 (25%) | 6 (20.69%) | 13 (22.81%) |
Former | 3 (10.71%) | 1 (3.45%) | 4 (7.02%) |
Never | 10 (35.71%) | 19 (65.52%) | 29 (50.88%) |
Unknown | 8 (28.57%) | 3 (10.34%) | 11 (19.30%) |
Tumor stage | Â | Â | Â |
Stage I | 16 (57.14%) | Â | Â |
Stage II | 3 (10.71%) | Â | Â |
Stage III | 8 (28.57%) | Â | Â |
Stage IV | 1 (3.57%) | Â | Â |
Histology subtype | Â | Â | Â |
Adenosquamous carcinoma | 25 (89.29%) | Â | Â |
Squamous cell carcinomas | 3 (10.71%) | Â | Â |
Hamartoma | Â | 4 (13.79%) | Â |
Infection | Â | 7 (24.14%) | Â |
Inflammation | Â | 3 (10.34%) | Â |
Tuberculosis | Â | 12 (41.38%) | Â |
unknown | Â | 3 (10.34%) | Â |
Total | 28 (49.12%) | 29 (50.88%) | 57 |